This page was reviewed under our medical and editorial policy by
Farshid Sadeghi, MD, Medical Director, Genitourinary Cancer Center, City of Hope Phoenix
This page was updated on December 19, 2022.
Prostate cancer is the most common cancer in men after skin cancer, so it’s important to understand the basics of the disease, as well as the prostate cancer risk factors.
The symptoms of prostate cancer may be different for each man, and any one of these symptoms may be caused by other conditions such as an enlarged prostate, prostatitis or benign prostatic hyperplasia (BPH). As a result, routine screening tests in the form of digital rectal exams (DRE) and prostate-specific antigen (PSA) tests are vital.
This article will cover:
In more advanced prostate cancers, because the cancer may extend from the periphery of the prostate toward its center, it may block the passage of urine through the prostate and lead to urinary symptoms, including:
However, a large subset of patients with advanced-stage prostate cancer do not exhibit urinary symptoms. Diagnosing even more advanced stages of prostate cancer remains heavily dependent on PSA monitoring and the performance of a digital rectal exam.
Men with advanced prostate cancer may experience additional symptoms. That’s because the cancer has spread from the prostate to other parts of the body, such as the bones or lymph nodes.
Signs of metastatic prostate cancer may include:
A wide range of treatment options are available for managing advanced cancer. These treatments kill cancer cells, but they may also help patients manage pain.
Prostate cancer that returns after treatment is considered recurrent. When it returns to the area around the prostate, the disease is classified as a local recurrence. If the cancer is found in another part of the body, the recurrent cancer is considered metastatic. If the cancer metastasizes (or spreads) outside the prostate, it most likely develops in the lymph nodes and bones first. Metastatic prostate cancer less commonly spreads to the liver or lungs.
After initial treatment for prostate cancer, PSA levels are expected to drop dramatically. The first sign of recurrent prostate cancer may be a rise in the PSA level as seen on a blood test. Other symptoms of recurrent cancer may depend on whether and where the cancer has spread. Symptoms include:
Patients should discuss any symptoms with their doctor and ask about scheduling regular PSA tests after treatment.
There is no one age for prostate cancer testing, but the American Cancer Society (ACS) makes recommendations about prostate cancer screenings based on age and family history. According to the ACS, patients in any of these groups should consider asking their doctor about testing: